NSE ScannerComparison · NSE · data 2026-10-30
Sun Pharmaceutical Industries Limited vs Zydus Lifesciences Limited
In plain words
Size: Sun Pharmaceutical Industries Limited is about 3.6 times the market value of Zydus Lifesciences Limited.
Valuation (P/E): Sun Pharmaceutical Industries Limited 35.3 vs Zydus Lifesciences Limited 27.8.
Return on equity: Zydus Lifesciences Limited 19.7% vs Sun Pharmaceutical Industries Limited 14.7%.
Profit growth over 3 years: Zydus Lifesciences Limited 37% a year vs Sun Pharmaceutical Industries Limited 10.6% a year.
Debt to equity: Zydus Lifesciences Limited 0.46 vs Sun Pharmaceutical Industries Limited 0.06.
Differences in the numbers, not a recommendation of either stock.
Side by side
| SUNPHARMA | ZYDUSLIFE | |
|---|---|---|
| Price | ₹1,777.7 | ₹1,245.5 |
| Market cap | ₹4,22,981 cr | ₹1,18,304 cr |
| P/E | 35.3 | 27.8 |
| P/B | — | — |
| ROE | 14.7% | 19.7% |
| ROCE | 17.7% | 17.8% |
| Debt / equity | 0.06 | 0.46 |
| Operating margin | 22.9% | 18.6% |
| Dividend yield | 0.91% | 0.08% |
| Sales growth, 3 years (yearly) | 9.9% | 16.6% |
| Profit growth, 3 years (yearly) | 10.6% | 37.0% |
| 1-year return | 3.6% | 24.1% |
| Revenue, last 12 months | ₹59,911 cr | ₹28,592 cr |
| Net profit, last 12 months | ₹12,096 cr | ₹4,513 cr |
| Latest quarter | Dec 2024 | Mar 2024 |
| Quarter net profit | ₹2,903 cr | ₹64 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 54.48% | 75.01% |
| Health check | Strong (7/10) | Strong (7.9/10) |
Common questions
Which has a higher P/E, Sun Pharmaceutical Industries Limited or Zydus Lifesciences Limited?
Sun Pharmaceutical Industries Limited trades at the higher P/E (35.3 against 27.8). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Zydus Lifesciences Limited (19.7% against 14.7%).
Which carries more debt?
Zydus Lifesciences Limited has the higher debt-to-equity ratio (0.46 against 0.06).